UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
基本信息
- 批准号:8334799
- 负责人:
- 金额:$ 43.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-16 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The UMass Mouse Metabolic Phenotyping Center involves a multidisciplinary group of investigators at UMass who perform an array of novel and sophisticated metabolic experiments using state-of-the-art equipment for the purpose of investigating transgenic mice useful for understanding diabetes and its complications. The goal of the UMass MMPC is to provide comprehensive metabolic characterization of transgenic mice using unique and standardized techniques mostly involving, in vivo and physiological setting that are complemented by analytical experiments using serum/tissue samples and measure of cardiovascular complications using non-invasive procedures in mice. The UMass MMPC consists of 3 Phenotyping Cores: 1) Metabolism Core applies hyperinsullnemic-euglycemic clamp to assess insulin sensitivity and glucose metabolism in individual organs, hyperglycemic clamp to assess pancreatic beta-cell function in conscious mice, metabolic cages to assess energy expenditure, activity and food intake, and 1H-MRS to measure fat/lean/water mass in mice, 2) Analytical Core uses Luminex. Meso Scale Discovery, and Cobas Clinical Chemistry Analyzer to provide a high-throughput and multiplexed measurement of serum/tissue levels of hormones, cytokines and metabolites, performs molecular experiments to examine insulin signaling, and conducts histological studies to examine tissues, 3) Cardiovascular Complications Core uses Vevo2100 In Vivo Imaging System to conduct echocardiography and tissue Doppler imaging, and CODA blood pressure device to examine cardiovascular abnormalities associated with diabetes. Mice provided by the users are overseen by the Animal Care Core that processes the receiving, quarantine, and housing of mice. Lastly, financial and administrative operation, research & development program, and website & database are managed by the Administrative Core. Overall, the aim of the UMass MMPC is to become an NIH-funded national center that offers elegant and standardized techniques and scientific expertise using a fee-for-service structure to characterize the metabolic and organ function phenotypes of transgenic mice and provide important insights into the mechanism of diabetes and its complications.
描述(由申请人提供):UMass小鼠代谢表型涉及UMass的多学科研究人员组,他们使用最先进的设备进行了一系列新颖而复杂的代谢实验,以研究用于研究转基因小鼠的目的,可用于了解糖尿病及其复杂性。 UMASS MMPC的目的是使用独特的和标准化的技术在体内和生理环境中提供转基因小鼠的全面代谢表征,通过使用血清/组织样本进行分析实验,并使用小鼠中的非侵入性手术来补充分析实验。 UMASS MMPC由3个表型核心组成:1)代谢核心应用高囊肿液态夹具评估单个器官中胰岛素敏感性和葡萄糖代谢的胰岛素敏感性和葡萄糖代谢,高血糖钳位,评估胰腺β-纤维培养基在评估意识的β-纤维化质量,以评估能量的跨度和食物的临界,并进行较大的益处和食物,并进行了代谢,活动,活动,活动,活动,活动,活动,活动,活动和食物的效果,活动/食物的效果,活动/食物的效果,活动/食物的效果,活动量和食物的作用。在小鼠中,2)分析核心使用Luminex。 MESO量表发现和COBAS临床化学分析仪,可提供对激素,细胞因子和代谢物的血清/组织水平的高通量和多路复用测量,执行分子实验,以检查胰岛素信号传导,以检查胰岛素信号,并进行组织学研究以检查组织,3)核心核心,3)Cardiascular Instry contrice conteriation consuction consuction consuction consuction consution for Veivo2100 Invivo Invocosigh多普勒成像和CODA血压装置检查与糖尿病有关的心血管异常。用户提供的小鼠由动物护理核心监督,该动物护理核心处理小鼠的接收,隔离和住房。最后,财务和行政运营,研发计划以及网站和数据库由行政核心管理。总体而言,UMass MMPC的目的是成为NIH资助的国家中心,该中心使用费用的服务结构提供优雅,标准化的技术和科学专业知识,以表征转基因小鼠的代谢和器官功能表型,并为糖尿病机制及其并发症的机制提供重要的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
JASON K KIM的其他基金
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
- 批准号:1073541910735419
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
- 批准号:95178549517854
- 财政年份:2011
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
- 批准号:1041188310411883
- 财政年份:2011
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
- 批准号:85177028517702
- 财政年份:2011
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
- 批准号:87080498708049
- 财政年份:2011
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
UMass Mouse Metabolic Phenotyping Center
麻省大学小鼠代谢表型中心
- 批准号:81937468193746
- 财政年份:2011
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
Interleukin-10 and Regulation of Skeletal Muscle Insulin Action
IL-10 和骨骼肌胰岛素作用的调节
- 批准号:83251678325167
- 财政年份:2008
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
Interleukin-10 and Regulation of Skeletal Muscle Insulin Action
IL-10 和骨骼肌胰岛素作用的调节
- 批准号:81383538138353
- 财政年份:2008
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
Interleukin-10 and Regulation of Skeletal Muscle Insulin Action
IL-10 和骨骼肌胰岛素作用的调节
- 批准号:76886177688617
- 财政年份:2008
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
Interleukin-10 and Regulation of Skeletal Muscle Insulin Action
IL-10 和骨骼肌胰岛素作用的调节
- 批准号:79088777908877
- 财政年份:2008
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
相似国自然基金
转录因子BACH1上调精氨酸酶ARG2促进高血压的作用和机制研究
- 批准号:82370434
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
血管周围脂肪组织TRPV1通道通过脂联素调控肥胖相关高血压的机制研究
- 批准号:82300500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
牙周细菌对高血压的作用和干预研究
- 批准号:82330015
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
BMP9通过CXCL1/CXCR2轴诱导高血压发生的机制研究
- 批准号:82370436
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
miR-3656–Krüppel样因子10–IL-9与高血压微血管稀疏化的关联及作用机制研究
- 批准号:82373666
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Impact of Medicaid Postpartum Coverage Extension and Mandated Postpartum Depression Screening on Care for Gestational Diabetes and Pregnancy-Induced Hypertension
医疗补助产后覆盖范围扩大和强制性产后抑郁症筛查对妊娠期糖尿病和妊娠高血压综合征护理的影响
- 批准号:1074937810749378
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
1/2 改善血管疾病的结果 - 主动脉夹层 (IMPROVE-AD)
- 批准号:1066303710663037
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
iCardia4HF: A multi-component mHealth app and tailored text-messaging intervention to promote self-care adherence and improve outcomes in patients with chronic heart failure
iCardia4HF:一款多组件移动医疗应用程序和定制短信干预,可促进慢性心力衰竭患者的自我护理依从性并改善预后
- 批准号:1063935710639357
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core
提高女性高血压患者的意识:ROAR(农村、肥胖、高危)职业提升核心
- 批准号:1071453510714535
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别:
A Smart Ring for Cuffless Blood Pressure to Reduce Health Disparities in People of Color
用于无袖血压测量的智能环,可减少有色人种的健康差异
- 批准号:1072034810720348
- 财政年份:2023
- 资助金额:$ 43.25万$ 43.25万
- 项目类别: